SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-004770
Filing Date
2022-03-30
Accepted
2022-03-30 16:48:59
Documents
116
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K rvlp-20211231x10k.htm   iXBRL 10-K 2805209
2 EX-4.4 rvlp-20211231xex4d4.htm EX-4.4 116554
3 EX-10.7 rvlp-20211231xex10d7.htm EX-10.7 35786
4 EX-10.8 rvlp-20211231xex10d8.htm EX-10.8 77184
5 EX-10.10 rvlp-20211231xex10d10.htm EX-10.10 183830
6 EX-10.11 rvlp-20211231xex10d11.htm EX-10.11 105101
7 EX-10.13 rvlp-20211231xex10d13.htm EX-10.13 171343
8 EX-10.14 rvlp-20211231xex10d14.htm EX-10.14 17771
9 EX-21.1 rvlp-20211231xex21d1.htm EX-21.1 6253
10 EX-23.1 rvlp-20211231xex23d1.htm EX-23.1 7536
11 EX-31.1 rvlp-20211231xex31d1.htm EX-31.1 9513
12 EX-31.2 rvlp-20211231xex31d2.htm EX-31.2 9602
13 EX-32.1 rvlp-20211231xex32d1.htm EX-32.1 8274
14 EX-32.2 rvlp-20211231xex32d2.htm EX-32.2 8266
15 GRAPHIC rvlp-20211231x10k002.jpg GRAPHIC 12559
16 GRAPHIC rvlp-20211231x10k003.jpg GRAPHIC 13121
  Complete submission text file 0001558370-22-004770.txt   13224376

Data Files

Seq Description Document Type Size
17 EX-101.SCH rvlp-20211231.xsd EX-101.SCH 81972
18 EX-101.CAL rvlp-20211231_cal.xml EX-101.CAL 129068
19 EX-101.DEF rvlp-20211231_def.xml EX-101.DEF 372834
20 EX-101.LAB rvlp-20211231_lab.xml EX-101.LAB 802832
21 EX-101.PRE rvlp-20211231_pre.xml EX-101.PRE 634962
110 EXTRACTED XBRL INSTANCE DOCUMENT rvlp-20211231x10k_htm.xml XML 2150132
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38709 | Film No.: 22787193
SIC: 2834 Pharmaceutical Preparations